Presentation is loading. Please wait.

Presentation is loading. Please wait.

Stromal Macrophage Expressing CD204 is Associated with Tumor Aggressiveness in Lung Adenocarcinoma  Yoichi Ohtaki, MD, Genichiro Ishii, MD, PhD, Kanji.

Published byDoddy Indradjaja Modified over 5 years ago

Similar presentations

Presentation on theme: "Stromal Macrophage Expressing CD204 is Associated with Tumor Aggressiveness in Lung Adenocarcinoma  Yoichi Ohtaki, MD, Genichiro Ishii, MD, PhD, Kanji."— Presentation transcript:

1 Stromal Macrophage Expressing CD204 is Associated with Tumor Aggressiveness in Lung Adenocarcinoma 
Yoichi Ohtaki, MD, Genichiro Ishii, MD, PhD, Kanji Nagai, MD, PhD, Satoshi Ashimine, MD, Takeshi Kuwata, MD, Tomoyuki Hishida, MD, PhD, Mitsuyo Nishimura, MD, PhD, Junji Yoshida, MD, PhD, Izumi Takeyoshi, MD, PhD, Atsushi Ochiai, MD, PhD  Journal of Thoracic Oncology  Volume 5, Issue 10, Pages (October 2010) DOI: /JTO.0b013e3181eba692 Copyright © 2010 International Association for the Study of Lung Cancer Terms and Conditions

2 FIGURE 1 Immunostaining of stromal CD68+ macrophages (A and B) and CD204+ macrophages (C and D). A, CD68 macrophages (low number), (B) CD68 macrophages (high number), (C) CD204 macrophages (low number), and (D) CD204 macrophages (high number). Journal of Thoracic Oncology 2010 5, DOI: ( /JTO.0b013e3181eba692) Copyright © 2010 International Association for the Study of Lung Cancer Terms and Conditions

3 FIGURE 2 Distribution of CD68+ and CD204+ macrophages. A, Correlations between the distribution of CD68+ macrophages and CD204+ macrophages of each case are shown. The numbers of CD204+ macrophages were significantly correlated with the numbers of CD68+ macrophages (r2 = , p < 0.001). B, The mean number of CD68-positive macrophages and CD204-positive macrophages was 30.6 ± 1.8 (median: 25, range: 0–120) and 24.8 ± 2.0 (median: 15, range: 0–143), respectively. Journal of Thoracic Oncology 2010 5, DOI: ( /JTO.0b013e3181eba692) Copyright © 2010 International Association for the Study of Lung Cancer Terms and Conditions

4 FIGURE 3 Numbers of CD68+ macrophages (A) and CD204+ macrophages (B) in each histologically predominant subtype (bronchioloalveolar carcinoma [BAC], papillary, acinar, and solid). Journal of Thoracic Oncology 2010 5, DOI: ( /JTO.0b013e3181eba692) Copyright © 2010 International Association for the Study of Lung Cancer Terms and Conditions

5 FIGURE 4 Kaplan-Meier analysis of overall survival. Kaplan-Meier analysis of overall survival according to the level of infiltration by CD68+ macrophages (A) and by CD204+ macrophages (B). Data were dichotomized at the median value for each parameter. Journal of Thoracic Oncology 2010 5, DOI: ( /JTO.0b013e3181eba692) Copyright © 2010 International Association for the Study of Lung Cancer Terms and Conditions

6 FIGURE 5 Correlations between the levels of expression of factors and numbers of CD204+ macrophages. A, The levels of expression shown are ratios of expression in cancer tissue to expression in noncancerous tissue. The ratios are expressed as means ± standard deviation. Expression of IL-10 (p = ) and MCP-1 (p = ) was significantly higher in the CD204high group (n = 9) than in the CD204low group (n = 9). The differences in expression of IL-6 (p = 0.122), IL-12a (p = 0.666), IL-12b (p = 0.436), M-CSF (p = 0.284), and IFN-gamma-. (p = 0.233) were not significant. B, Correlations between levels of IL-10 and MCP-1 expression (ratios of expression in cancer tissue to expression in noncancerous tissue) and the distribution of CD204+ macrophages of each case are shown. The numbers of CD204-positive macrophages were significantly correlated with the increases in the ratios of IL-10 expression (r2 = 0.580, p < 0.001) and MCP-1 expression (r2 = 0.641, p < 0.001). Journal of Thoracic Oncology 2010 5, DOI: ( /JTO.0b013e3181eba692) Copyright © 2010 International Association for the Study of Lung Cancer Terms and Conditions

Download ppt "Stromal Macrophage Expressing CD204 is Associated with Tumor Aggressiveness in Lung Adenocarcinoma  Yoichi Ohtaki, MD, Genichiro Ishii, MD, PhD, Kanji."

Similar presentations

Jarrod D. Predina, BA, Matthew M. Puc, MD, Meredith R

Jarrod D. Predina, BA, Matthew M. Puc, MD, Meredith R
Limited resection trial for pulmonary ground-glass opacity nodules: Fifty-case experience  Junji Yoshida, MD, Kanji Nagai, MD, Tomoyuki Yokose, MD, Mitsuyo.

Limited resection trial for pulmonary ground-glass opacity nodules: Fifty-case experience  Junji Yoshida, MD, Kanji Nagai, MD, Tomoyuki Yokose, MD, Mitsuyo.
Primary Signet-Ring Carcinoma (SRC) of the Lung: A Population-Based Epidemiologic Study of 262 Cases with Comparison to Adenocarcinoma of the Lung  Sai-Hong.

Primary Signet-Ring Carcinoma (SRC) of the Lung: A Population-Based Epidemiologic Study of 262 Cases with Comparison to Adenocarcinoma of the Lung  Sai-Hong.
Carcinoma NOS is a Common Histologic Diagnosis and is Increasing in Proportion Among Non-small Cell Lung Cancer Histologies  Sai-Hong Ignatius Ou, MD,

Carcinoma NOS is a Common Histologic Diagnosis and is Increasing in Proportion Among Non-small Cell Lung Cancer Histologies  Sai-Hong Ignatius Ou, MD,
Histopathologic Prognostic Factors in Resected Colorectal Lung Metastases  Satoshi Shiono, MD, Genichiro Ishii, MD, Kanji Nagai, MD, Junji Yoshida, MD,

Histopathologic Prognostic Factors in Resected Colorectal Lung Metastases  Satoshi Shiono, MD, Genichiro Ishii, MD, Kanji Nagai, MD, Junji Yoshida, MD,
Limited resection trial for pulmonary ground-glass opacity nodules: Fifty-case experience  Junji Yoshida, MD, Kanji Nagai, MD, Tomoyuki Yokose, MD, Mitsuyo.

Limited resection trial for pulmonary ground-glass opacity nodules: Fifty-case experience  Junji Yoshida, MD, Kanji Nagai, MD, Tomoyuki Yokose, MD, Mitsuyo.
A Novel Classification of MUC1 Expression Is Correlated with Tumor Differentiation and Postoperative Prognosis in Non–Small Cell Lung Cancer  Shinjiro.

A Novel Classification of MUC1 Expression Is Correlated with Tumor Differentiation and Postoperative Prognosis in Non–Small Cell Lung Cancer  Shinjiro.
Long-Term Survival in Two Cases of Resected Gastric Metastasis of Pulmonary Pleomorphic Carcinoma  Keiju Aokage, MD, Junji Yoshida, MD, Genichiro Ishii,

Long-Term Survival in Two Cases of Resected Gastric Metastasis of Pulmonary Pleomorphic Carcinoma  Keiju Aokage, MD, Junji Yoshida, MD, Genichiro Ishii,
Bronchioloalveolar Carcinoma (Lepidic Growth) Component Is a More Useful Prognostic Factor than Lymph Node Metastasis  Yoichi Anami, MD, Tatsuo Iijima,

Bronchioloalveolar Carcinoma (Lepidic Growth) Component Is a More Useful Prognostic Factor than Lymph Node Metastasis  Yoichi Anami, MD, Tatsuo Iijima,
Results of Surgical Treatment for Patients with Small Cell Lung Cancer

Results of Surgical Treatment for Patients with Small Cell Lung Cancer
The impact on survival of positive intraoperative pleural lavage cytology in patients with non–small-cell lung cancer  Keiju Aokage, MD, Junji Yoshida,

The impact on survival of positive intraoperative pleural lavage cytology in patients with non–small-cell lung cancer  Keiju Aokage, MD, Junji Yoshida,
Nicolas Girard, MD, Julie Teruya-Feldstein, MD, Eden C

Nicolas Girard, MD, Julie Teruya-Feldstein, MD, Eden C
Susan C. Scott, MD, Nathan A. Pennell, MD, PhD 

Susan C. Scott, MD, Nathan A. Pennell, MD, PhD 
Programmed Cell Death Ligand 1 Expression in Resected Lung Adenocarcinomas: Association with Immune Microenvironment  Tiffany G. Huynh, BA, Vicente Morales-Oyarvide,

Programmed Cell Death Ligand 1 Expression in Resected Lung Adenocarcinomas: Association with Immune Microenvironment  Tiffany G. Huynh, BA, Vicente Morales-Oyarvide,
Prognostic Impact of CD204-Positive Macrophages in Lung Squamous Cell Carcinoma: Possible Contribution of Cd204-Positive Macrophages to the Tumor-Promoting.

Prognostic Impact of CD204-Positive Macrophages in Lung Squamous Cell Carcinoma: Possible Contribution of Cd204-Positive Macrophages to the Tumor-Promoting.
Electronic Updates for JTO Readers

Electronic Updates for JTO Readers
Predictive Factors for Local Recurrence of Resected Colorectal Lung Metastases  Satoshi Shiono, MD, Genichiro Ishii, MD, Kanji Nagai, MD, Junji Yoshida,

Predictive Factors for Local Recurrence of Resected Colorectal Lung Metastases  Satoshi Shiono, MD, Genichiro Ishii, MD, Kanji Nagai, MD, Junji Yoshida,
Differences of tumor microenvironment between stage I lepidic-positive and lepidic- negative lung adenocarcinomas  Shinya Katsumata, MD, Keiju Aokage,

Differences of tumor microenvironment between stage I lepidic-positive and lepidic- negative lung adenocarcinomas  Shinya Katsumata, MD, Keiju Aokage,
Mediastinal Nodal Involvement in Patients with Clinical Stage I Non–Small-Cell Lung Cancer: Possibility of Rational Lymph Node Dissection  Tomohiro Haruki,

Mediastinal Nodal Involvement in Patients with Clinical Stage I Non–Small-Cell Lung Cancer: Possibility of Rational Lymph Node Dissection  Tomohiro Haruki,
Prognostic Factors in Completely Resected Node-Negative Lung Adenocarcinoma of 3 cm or Smaller  Jung-Jyh Hung, MD, PhD, Yi-Chen Yeh, MD, Yu-Chung Wu,

Prognostic Factors in Completely Resected Node-Negative Lung Adenocarcinoma of 3 cm or Smaller  Jung-Jyh Hung, MD, PhD, Yi-Chen Yeh, MD, Yu-Chung Wu,

Similar presentations

Ads by Google